NCT05014867

Brief Summary

Published data on sequential transfer are limited and are not consistent. Also, further research into methods of risk combination and assessment, would allow us to help our patients make better-informed decisions about whether or not to proceed with invasive diagnostic tests as the PGS. So our study aims to describe the ongoing pregnancy rate for poor responders women undergoing four different embryo transfer protocols among four arms within the study. Moreover, to describe the miscarriage rate, and the baseline characteristics for the same population. This clinical study will be conducted in compliance with the clinical study protocol and applicable regulatory requirements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
291

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 20, 2021

Completed
21 days until next milestone

Study Start

First participant enrolled

September 10, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2024

Completed
Last Updated

July 28, 2025

Status Verified

July 1, 2025

Enrollment Period

2.1 years

First QC Date

August 14, 2021

Last Update Submit

July 23, 2025

Conditions

Keywords

Poor respondersPGSSequentialEmbryo transfer

Outcome Measures

Primary Outcomes (1)

  • ongoing pregnancy rate for poor responders women in the four arms

    Recording the following for the four arms of the study: * Presence of intrauterine gestational sac at 12 weeks beyond embryo transfer * Presence of fetal heart pulsation at 12 weeks beyond embryo transfer

    Till the end of 12 weeks of gestation

Secondary Outcomes (2)

  • miscarriage rate for poor responders women in the four arms

    Till the end of 20 weeks of gestation

  • The baseline characteristics of the study participants

    Before study intervention of the four arms (at day 2 in the ovulation induction cycle)

Study Arms (4)

Arm 1

Poor responders women undergoing frozen sequential embryo transfer on Day 3 and Day 5

Procedure: Embryo transfer method

Arm 2

Poor responders women undergoing sequential fresh embryo transfer on Day 3 and Day 5

Procedure: Embryo transfer method

Arm 3

Poor responders women undergoing sequential embryo transfer on Day 3 and Day 5 after performing PGS

Procedure: Embryo transfer method

Arm 4

Poor responders women undergoing conventional frozen embryo transfer on Day 5

Procedure: Embryo transfer method

Interventions

1. Sequential embryo transfer on day 3 and day 5 in a frozen cycle 2. Sequential embryo transfer on day 3 and day 5 in a fresh cycle 3. Sequential embryo transfer on day 3 and day 5 after performing PGS 4. Conventional Day 5 frozen embryo transfer

Arm 1Arm 2Arm 3Arm 4

Eligibility Criteria

Age25 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Poor responders women undergoing one of the following: 1. Sequential embryo transfer on day 3 and day 5 in a frozen cycle 2. Sequential embryo transfer on day 3 and day 5 in a fresh cycle 3. Sequential embryo transfer on day 3 and day 5 after performing PGS 4. Conventional Day 5 frozen embryo transfer

You may qualify if:

  • The age group of these women is 25-45 years
  • Normal endometrial cavity confirmed by hysteroscopy
  • Poor responders with AMH \<1
  • Patients with at least grade 1 days 3 embryo and grade 1 day 5 frozen embryos

You may not qualify if:

  • Patients with any immunological disorders
  • Patients with uncontrolled systemic diseases
  • Patients with previous uterine surgeries except for Cesarean section

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wael Elbanna Clinic

Cairo, Egypt

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Managing director for Wael Elbanna Clinic

Study Record Dates

First Submitted

August 14, 2021

First Posted

August 20, 2021

Study Start

September 10, 2021

Primary Completion

October 20, 2023

Study Completion

November 12, 2024

Last Updated

July 28, 2025

Record last verified: 2025-07

Locations